000			01540 a2200457 4500
005			20250515183711.0
264		0	_c20090929
008			200909s 0 0 eng d
022			_a1471-2377
024	7		_a10.1186/1471-2377-9-46 _2doi
040			_aNLM _beng _cNLM
100	1		_aCalmels, Nadège
245	0	0	_aLimitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen. _h[electronic resource]
260			_bBMC neurology _cAug 2009
300			_a46 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBlotting, Western
650	0	4	_aCell Line _xcytology
650	0	4	_aCell Proliferation
650	0	4	_aCells, Cultured
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFriedreich Ataxia _xdrug therapy
650	0	4	_aGene Knockdown Techniques
650	0	4	_aIron-Binding Proteins _xgenetics
650	0	4	_aIron-Sulfur Proteins _xgenetics
650	0	4	_aMice
650	0	4	_aMitochondrial Proteins _xgenetics
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aFrataxin
700	1		_aSeznec, Hervé
700	1		_aVilla, Pascal
700	1		_aReutenauer, Laurence
700	1		_aHibert, Marcel
700	1		_aHaiech, Jacques
700	1		_aRustin, Pierre
700	1		_aKoenig, Michel
700	1		_aPuccio, Hélène
773	0		_tBMC neurology _gvol. 9 _gp. 46
856	4	0	_uhttps://doi.org/10.1186/1471-2377-9-46 _zAvailable from publisher's website
999			_c19105202 _d19105202